Drug-Eluting Stents Versus Bare-Metal Stents in Saphenous Vein Graft Intervention
Nileshkumar Patel(Detroit Medical Center), Deepak L. Bhatt(Mount Sinai Hospital), Mauricio G. Cohen(Santa Ana College), Varunsiri Atti(B.J. Medical College), Samin K. Sharma(Mount Sinai Health System), George Dangas(Mount Sinai Hospital), Chirag Bavishi(St. Luke's-Roosevelt Hospital Center), Annapoorna Kini(Mount Sinai Medical Center), Nikhil Nalluri(Tulane University), Avnish Tripathi(Massachusetts General Hospital)
Cited by 23
Related Papers
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
|New England Journal of Medicine|2018|6.3k
Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome
|New England Journal of Medicine|2018|3.5k
Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia
|New England Journal of Medicine|2018|3.2k
A Controlled Trial of Renal Denervation for Resistant Hypertension
|New England Journal of Medicine|2014|2.2k
Long-Term Use of Ticagrelor in Patients with Prior Myocardial Infarction
|New England Journal of Medicine|2015|2k